Atalanta Sosnoff Capital Trimmed Pfizer (PFE) Stake; Pcm (PCMI) Shorts Increased By 10.28%

PCM, Inc. (NASDAQ:PCMI) Logo

Atalanta Sosnoff Capital Llc decreased Pfizer Inc (PFE) stake by 2.83% reported in 2018Q1 SEC filing. Atalanta Sosnoff Capital Llc sold 18,823 shares as Pfizer Inc (PFE)’s stock declined 3.80%. The Atalanta Sosnoff Capital Llc holds 647,034 shares with $22.96 million value, down from 665,857 last quarter. Pfizer Inc now has $211.81B valuation. The stock decreased 0.47% or $0.17 during the last trading session, reaching $36.21. About 27.89 million shares traded or 31.65% up from the average. Pfizer Inc. (NYSE:PFE) has risen 10.95% since June 28, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 05/03/2018 Japan 2018 Drug Price Revision: Ono Opdivo another 24% cut after 50% price cut ~1yr ago $MRK Keytruda 11% cut $PFE Bavencio 12% cut $AGN Botox 18% cut Chugai Rituxan 26% cut Chugai Herceptin 20% cut; 19/03/2018 – PFIZER SAYS FDA GRANTS PRIORITY REVIEW FOR SNDA FOR XTANDI; 19/04/2018 – ASEMBIA EXPANDS PACT WITH PFIZER ONCOLOGY; 01/05/2018 – Pfizer 1Q Innovative Health Rev $7.83B; 01/05/2018 – Pfizer Remaining Share-Repurchase Authorization $10.3B; 29/05/2018 – Roche: Study is on Tecentriq Plus Chemotherapy for Type of Lung Cancer; 24/05/2018 – Health Care Down as Pfizer, Recro Weighs — Health Care Roundup; 03/04/2018 – Jeffrey C. McCracken: Pfizer in talks with P&G on sale of its consumer business, though they are far apart on price; 03/04/2018 – PFIZER IN TALKS WITH P&G ON CONSUMER BUSINESS SALE – CNBC, CITING; 12/03/2018 – Biogen To Buy Schizophrenia Treatment From Pfizer For Up To $590 Million — MarketWatch

Pcm Inc (NASDAQ:PCMI) had an increase of 10.28% in short interest. PCMI’s SI was 1.14M shares in June as released by FINRA. Its up 10.28% from 1.03M shares previously. With 152,200 avg volume, 8 days are for Pcm Inc (NASDAQ:PCMI)’s short sellers to cover PCMI’s short positions. The SI to Pcm Inc’s float is 15.56%. The stock decreased 2.51% or $0.4 during the last trading session, reaching $15.55. About 89,130 shares traded. PCM, Inc. (NASDAQ:PCMI) has declined 39.25% since June 28, 2017 and is downtrending. It has underperformed by 51.82% the S&P500. Some Historical PCMI News: 07/03/2018 – PCM: Forecasting 2018 Revenue Growth of Approximately 5% Over 2017; 28/03/2018 – PCM at Sidoti & Company Spring Investor Conference Tomorrow; 21/03/2018 – PCM Company Marketing Scheduled By FBR for Mar. 28; 27/03/2018 – PCM Named Most Valuable National Solutions Provider by ESET; 21/03/2018 – PCM, Inc. Announces Participation in Sidoti & Company Spring 2018 Conference; 14/05/2018 – PCM at B. Riley FBR Institutional Investor Conference May 24; 17/04/2018 – Trovagene Presents Data at AACR Meeting 2018 on Pharmacodynamic and Tumor Biomarkers During Treatment with PCM-075 and Low-Dose Cytarabine; 02/05/2018 – Hennessy Advisors Inc. Exits Position in PCM; 07/03/2018 – PCM Sees FY18 Adj EPS $2-Adj EPS $2.10; 07/03/2018 – PCM 4Q Adj EPS 17c

Another recent and important PCM, Inc. (NASDAQ:PCMI) news was published by Businesswire.com which published an article titled: “PCM Named to CRN’s 2018 Solution Provider 500 List” on June 25, 2018.

PCM, Inc., through its subsidiaries, operates as a multi-vendor well-known provider of technology products and solutions primarily in the United States and Canada. The company has market cap of $184.08 million. The firm operates through three divisions: Commercial, Public Sector, and Canada. It has a 64.79 P/E ratio. It primarily sells device products, servers, storage products, networks, printers, and related accessories and devices.

Since February 24, 2018, it had 0 buys, and 13 insider sales for $18.09 million activity. Another trade for 132,312 shares valued at $4.76 million was sold by READ IAN C. Another trade for 13,986 shares valued at $501,398 was sold by Dolsten Mikael. Another trade for 27,323 shares valued at $998,666 was sold by JOHNSON RADY A. $353,677 worth of Pfizer Inc. (NYSE:PFE) shares were sold by LUND-JURGENSEN KIRSTEN. 5,223 shares were sold by CORNWELL W DON, worth $190,117. 42,393 Pfizer Inc. (NYSE:PFE) shares with value of $1.52M were sold by HILL CHARLES H. SUSMAN SALLY also sold $1.24 million worth of Pfizer Inc. (NYSE:PFE) on Monday, February 26.

More important recent Pfizer Inc. (NYSE:PFE) news were published by: Streetinsider.com which released: “Pfizer (PFE) Secures Priority Review Designation and New Drug Application Acceptance for Glasdegib” on June 28, 2018, also Fool.com published article titled: “Is Pfizer’s Lead Growth Driver in Trouble?”, 247Wallst.com published: “Short Sellers Hike Bets in Major Pharma Stocks” on June 27, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) was released by: Seekingalpha.com and their article: “Pfizer – Still A Hold For The Dividend” with publication date: June 08, 2018.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 earnings per share, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39B for 12.07 P/E if the $0.75 EPS becomes a reality. After $0.77 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Atalanta Sosnoff Capital Llc increased Costco Whsl Corp New (NASDAQ:COST) stake by 37,232 shares to 104,134 valued at $19.62M in 2018Q1. It also upped Intel Corp (NASDAQ:INTC) stake by 840,478 shares and now owns 1.47 million shares. Boston Scientific Corp (NYSE:BSX) was raised too.

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It fall, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Crossvault Cap Limited Company holds 32,496 shares or 0.66% of its portfolio. Sound Shore Ct owns 5.75 million shares or 3.3% of their US portfolio. Pettyjohn Wood & White invested 0.97% in Pfizer Inc. (NYSE:PFE). Doheny Asset Mgmt Ca stated it has 53,204 shares. Godsey & Gibb, a Virginia-based fund reported 398,444 shares. Amundi Pioneer Asset Mngmt Incorporated reported 0.87% of its portfolio in Pfizer Inc. (NYSE:PFE). Professional Advisory Incorporated reported 0.21% of its portfolio in Pfizer Inc. (NYSE:PFE). Ifrah Fincl Ser reported 0.37% in Pfizer Inc. (NYSE:PFE). Moreover, Violich Mngmt Inc has 0.27% invested in Pfizer Inc. (NYSE:PFE). Amica Pension Fund Board Of Trustees, Rhode Island-based fund reported 197,308 shares. Oakwood Capital Ltd Liability Ca owns 144,102 shares or 2.18% of their US portfolio. 201,650 are held by Keystone Fin Planning. Phocas Finance Corporation invested in 5,961 shares or 0% of the stock. Hoertkorn Richard Charles holds 0.59% or 27,125 shares. 1.84M were accumulated by South Dakota Investment Council.

PCM, Inc. (NASDAQ:PCMI) Institutional Positions Chart